Considering the importance of the EU market, Biova pursued Novel Food status for its patented water-soluble egg membrane ingredients. As the first to be approved, Biova will have exclusivity in the EU for a term of five years.
“This is a tremendous achievement for Biova and a result of several years of teamwork,” said Biova CEO Pat Schneider. “Providing the necessary documentation on the safety and efficacy of our ingredients and have this awarded with the approval will make a big impact in our international sales efforts.”
Novel Foods approval means that companies can import Biova’s ingredients into EU member countries without concern of being stopped at the borders. Amanda Orloske, Biova’s senior director of marketing and international sales, also noted that “U.S. customers will also have a wider range of global expansion opportunities with our ingredients now.”